Acute lymphoblastic leukaemia trials in Brazil

In Brazil 10 Also abroad 563

10 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Asciminib Roll-over Study
Where
Rio de Janeiro, São Paulo
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
No phaseTaking people
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Where
São Paulo
Age
16 years to 50 years
People
180
Run by
Instituto do Cancer do Estado de São Paulo
See details and how to joinNCT05959720
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Barretos, Curitiba, Porto Alegre, São José do Rio Preto
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
Porto Alegre, São Paulo
Age
12 years and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
Phase 1Taking people
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
Where
São Paulo
Age
2 years to 70 years
People
30
Run by
Nelson Hamerschlak
See details and how to joinNCT05705570
No phaseTaking people
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Where
Barretos, Recife, São Paulo
Age
3 years to 18 years
People
4,900 worldwide
Run by
Columbia University
See details and how to joinNCT05929976
No phaseTaking people
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Where
Curitiba, Minas Gerais, Salvador, São Paulo
Age
0 years to 100 years
People
200
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05541341
Phase 2Taking people
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Where
São Paulo
Age
16 years to 60 years
People
50
Run by
Instituto do Cancer do Estado de São Paulo
See details and how to joinNCT06034561
Phase 1/2Taking people
PTCy and ATG for MSD and MUD Transplants
Where
Rio de Janeiro
Age
18 years to 60 years
People
50
Run by
Instituto Nacional de Cancer, Brazil
See details and how to joinNCT06299462
Phase 1/2Taking people
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
Where
Campinas, Ribeirão Preto, São Paulo
Age
3 years to 70 years
People
81
Run by
University of Sao Paulo
See details and how to joinNCT06101381